Validation of a Fibrinogen γ' Enzyme-linked Immunosorbent Assay Using a New Monoclonal Antibody: Effects of Bariatric Surgery

Overview

Journal Res Pract Thromb Haemost

Publisher Elsevier

Date 2024 Feb 21

PMID 38379712

Authors

Nadja Bodker Pedersen

Else-Marie Bladbjerg

Claus Bogh Juhl

Anette Larsen

Anna-Marie Bloch Munster

Moniek P M de Maat

Yaseelan Palarasah

Affiliations

Soon will be listed here.

Abstract

Background: Fibrinogen γ' is a naturally occurring 20-amino-acid splice variant of the fibrinogen γ chain. Animal studies link variations in fibrinogen to obesity, but it is unknown how fibrinogen γ' is associated with obesity in humans.

Objectives: To develop and validate an enzyme-linked immunosorbent assay (ELISA) for fibrinogen γ' quantification in human plasma and analyze fibrinogen γ' before and after bariatric surgery.

Methods: We generated C-terminal fibrinogen γ' specific mouse monoclonal antibodies and developed a γ' ELISA. Validation included measures of accuracy, sensitivity, and precision. Fibrinogen γ' and total fibrinogen were measured in 60 individuals before and 6 months after bariatric surgery and in 19 normal-weight controls and 120 blood donors.

Results: Highly specific fibrinogen γ' monoclonal antibodies were produced and successfully used in the ELISA. Recovery was 88%, and limits of detection and quantification were 0.003 mg/mL and 0.014 mg/mL, respectively. Coefficients of variation were 3% for repeatability and 7% for within-laboratory variation. The fibrinogen γ' reference interval was 0.25 to 0.80 mg/mL. Fibrinogen γ' concentrations were reduced after bariatric surgery and were higher in individuals with obesity than in those with normal weight. The fibrinogen γ'/total fibrinogen ratio was unchanged after surgery but was higher than the ratio in normal-weight individuals.

Conclusion: We developed a precise and sensitive ELISA for fibrinogen γ'. Levels of fibrinogen γ', but not the fibrinogen γ'/fibrinogen ratio, were reduced 6 months after bariatric surgery. Absolute and relative levels of fibrinogen γ' were increased in individuals with obesity compared to normal-weight individuals.

References

Armbruster D, Pry T . Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008; 29 Suppl 1:S49-52. PMC: 2556583. View

Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

Wolfenstein-Todel C, Mosesson M . Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). Biochemistry. 1981; 20(21):6146-9. DOI: 10.1021/bi00524a036. View

Cheung E, Vos H, Kruip M, den Hertog H, Jukema J, de Maat M . Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome. Blood. 2009; 114(20):4603-4. DOI: 10.1182/blood-2009-08-236240. View

Landin K, Tengborn L, Smith U . Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med. 1990; 227(4):273-8. DOI: 10.1111/j.1365-2796.1990.tb00157.x. View

Pieters M, Kotze R, Jerling J, Kruger A, Ariens R . Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans. Blood. 2013; 121(16):3254-60. DOI: 10.1182/blood-2012-12-471482. View

Lovely R, Hossain J, Ramsey J, Komakula V, George D, Farrell D . Obesity-related increased γ' fibrinogen concentration in children and its reduction by a physical activity-based lifestyle intervention: a randomized controlled study. J Pediatr. 2013; 163(2):333-8. DOI: 10.1016/j.jpeds.2013.01.004. View

Meh D, Siebenlist K, Brennan S, Holyst T, Mosesson M . The amino acid sequence in fibrin responsible for high affinity thrombin binding. Thromb Haemost. 2001; 85(3):470-4. View

Fornace Jr A, Cummings D, Comeau C, Kant J, Crabtree G . Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen. J Biol Chem. 1984; 259(20):12826-30. View

10.

Omarova F, Uitte de Willige S, Ariens R, Rosing J, Bertina R, Castoldi E . Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ'. J Thromb Haemost. 2013; 11(9):1669-78. DOI: 10.1111/jth.12354. View

11.

Cooper A, Standeven K, Ariens R . Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood. 2003; 102(2):535-40. DOI: 10.1182/blood-2002-10-3150. View

12.

Francis C, Kraus D, Marder V . Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three gamma-chain types with distinct molecular weights. Biochim Biophys Acta. 1983; 744(2):155-64. DOI: 10.1016/0167-4838(83)90085-7. View

13.

Henschen A . Human fibrinogen--structural variants and functional sites. Thromb Haemost. 1993; 70(1):42-7. View

14.

Fredenburgh J, Stafford A, Leslie B, Weitz J . Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. J Biol Chem. 2007; 283(5):2470-7. DOI: 10.1074/jbc.M707710200. View

15.

Lovely R, Falls L, Al-Mondhiry H, Chambers C, Sexton G, Ni H . Association of gammaA/gamma' fibrinogen levels and coronary artery disease. Thromb Haemost. 2002; 88(1):26-31. View

16.

Bladbjerg E, Stolberg C, Juhl C . Effects of Obesity Surgery on Blood Coagulation and Fibrinolysis: A Literature Review. Thromb Haemost. 2020; 120(4):579-591. DOI: 10.1055/s-0040-1702224. View

17.

Lovely R, Kazmierczak S, Massaro J, DAgostino Sr R, ODonnell C, Farrell D . Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease. Clin Chem. 2010; 56(5):781-8. PMC: 3033762. DOI: 10.1373/clinchem.2009.138347. View

18.

Francis C, Keele E, Marder V . Purification of three gamma-chains with different molecular weights from normal human plasma fibrinogen. Biochim Biophys Acta. 1984; 797(3):328-35. DOI: 10.1016/0304-4165(84)90253-8. View

19.

Drouet L, Paolucci F, Pasqualini N, Laprade M, Ripoll L, Mazoyer E . Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?. Blood Coagul Fibrinolysis. 1999; 10 Suppl 1:S35-9. View

20.

Danesh J, Lewington S, Thompson S, Lowe G, Collins R, Kostis J . Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005; 294(14):1799-809. DOI: 10.1001/jama.294.14.1799. View